Enzyme inhibition by antibodies
- PMID: 47683
- DOI: 10.1530/acta.0.080s133
Enzyme inhibition by antibodies
Abstract
The interest in the inhibition of enzymes by their specific antibodies stems mainly from the fact that these systems can serve as suitable models in the study of neutralization of biologically active molecules in general. The interaction of enzymes with their specific antibodies generally leads to a reduction in their enzymatic activity. The mechanism of this inhibition is rarely a direct combination of the antibodies with the catalytic site, but is rather due to steric hindrance, namely, barring the access to the active site. In several systems the mechanism of the antibody effect is by conformational changes which it induces on the enzyme. In these cases, the interaction with the antibody may result either in inhibition or in enhancement of the enzymatic activity. In every instance, however, the effect of the antibody is dependent on its narrow specificity, namely, on the regions of the enzyme to which it is directed. The extent of inhibition or enhancement is, therefore, a reflection of the nature and distribution of the various antigenic determinants on the enzyme molecule. Antibodies specific exclusively to defined regions of an enzyme molecule can be prepared. This has been performed for both lysozyme and staphylococcal nuclease by two procedures: a) Selective separation of the relevant antibodies from the anti-enzyme serum by an immunoadsorbent containing a particular immunologically active fragment of the enzyme. b) The use of an isolated antigenic fragment of the enzyme, or a conjugate of it, for immunization. The antibodies thus prepared, specific toward a unique defined region of the lysozyme molecule (residues 60-83, denoted "loop") recognize the structural conformation of the fragment and are reactive with the intact enzyme molecule. Furthermore, a chemically synthesized loop-like derivative was proved immunologically identical with the natural fragment, and when forming a part of a completely synthetic conjugate, elicited conformation-specific antibodies, reactive with native lysozyme. These findings are relevant to the topic of an immunological approach to fertility control from two different viewpoints: In the first place they are informative regarding the specific inhibition by antibodies of sperm enzymes which partake in the fertilization process. Secondly, they encourage the synthetic approach for induction of an immune response toward hormones which are crucial in fertilization or implantation.
Similar articles
-
Antibodies targeting enzyme inhibition as potential tools for research and drug development.Biomol Concepts. 2021 Dec 31;12(1):215-232. doi: 10.1515/bmc-2021-0021. Biomol Concepts. 2021. PMID: 35104929 Review.
-
Antibodies to a unique region in lysozyme provoked by a synthetic antigen conjugate.Proc Natl Acad Sci U S A. 1969 Jan;62(1):163-70. doi: 10.1073/pnas.62.1.163. Proc Natl Acad Sci U S A. 1969. PMID: 5253653 Free PMC article.
-
Studies on glutathione S-transferases important for sperm function: evidence of catalytic activity-independent functions.Biochem J. 1998 Jan 15;329 ( Pt 2)(Pt 2):231-41. doi: 10.1042/bj3290231. Biochem J. 1998. PMID: 9425104 Free PMC article.
-
Anti-idiotype antibodies prevent antibody binding to mouse sperm and antibody-mediated inhibition of fertilization.Biol Reprod. 1989 Jul;41(1):153-62. doi: 10.1095/biolreprod41.1.153. Biol Reprod. 1989. PMID: 2478201
-
The WHO Task Force on Vaccines for Fertility Regulation. Its formation, objectives and research activities.Hum Reprod. 1991 Jan;6(1):166-72. doi: 10.1093/oxfordjournals.humrep.a137252. Hum Reprod. 1991. PMID: 1874951 Review.
Cited by
-
Antiviral effect on MS-2 coliphage obtained with a synthetic antigen.Proc Natl Acad Sci U S A. 1976 Dec;73(12):4636-40. doi: 10.1073/pnas.73.12.4636. Proc Natl Acad Sci U S A. 1976. PMID: 63950 Free PMC article.
-
Vaccination with Schistosoma mansoni Cholinesterases Reduces the Parasite Burden and Egg Viability in a Mouse Model of Schistosomiasis.Vaccines (Basel). 2020 Apr 3;8(2):162. doi: 10.3390/vaccines8020162. Vaccines (Basel). 2020. PMID: 32260125 Free PMC article.
-
Antigen recognition by single-domain antibodies: structural latitudes and constraints.MAbs. 2018 Aug/Sep;10(6):815-826. doi: 10.1080/19420862.2018.1489633. Epub 2018 Aug 15. MAbs. 2018. PMID: 29916758 Free PMC article. Review.
-
Novel human recombinant antibodies against Mycobacterium tuberculosis antigen 85B.BMC Biotechnol. 2014 Jul 17;14:68. doi: 10.1186/1472-6750-14-68. BMC Biotechnol. 2014. PMID: 25033887 Free PMC article.